The store will not work correctly when cookies are disabled.
5-[(2(S)-Azetidinyl)methoxy]-3-[(N-cyclopentylcarbamoyloxy)methyl]isoxazole
ID: ALA2165442
PubChem CID: 56949919
Max Phase: Preclinical
Molecular Formula: C14H21N3O4
Molecular Weight: 295.34
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(NC1CCCC1)OCc1cc(OC[C@@H]2CCN2)on1
Standard InChI: InChI=1S/C14H21N3O4/c18-14(16-10-3-1-2-4-10)20-9-12-7-13(21-17-12)19-8-11-5-6-15-11/h7,10-11,15H,1-6,8-9H2,(H,16,18)/t11-/m0/s1
Standard InChI Key: UYZYLDHDYYFCFP-NSHDSACASA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
13.0079 -26.2701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.8329 -26.2701 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0896 -25.4860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.4204 -24.9993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.7554 -25.4860 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7995 -25.0659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.0372 -25.0701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.3221 -25.4816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6082 -25.0682 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3910 -24.2704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5939 -24.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8064 -25.2800 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.5184 -25.4707 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.5272 -26.2956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2461 -26.7004 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.8172 -26.7158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.2549 -27.5254 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5946 -28.0177 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8579 -28.7995 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6829 -28.7907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9293 -28.0033 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 1 1 0
3 6 1 0
5 7 1 0
7 8 1 0
9 8 1 1
9 10 1 0
10 11 1 0
11 12 1 0
12 9 1 0
6 13 1 0
13 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 17 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 295.34 | Molecular Weight (Monoisotopic): 295.1532 | AlogP: 1.58 | #Rotatable Bonds: 6 |
Polar Surface Area: 85.62 | Molecular Species: BASE | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 13.96 | CX Basic pKa: 9.61 | CX LogP: 0.85 | CX LogD: -1.32 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.83 | Np Likeness Score: -0.78 |
References
1. Yu LF, Tückmantel W, Eaton JB, Caldarone B, Fedolak A, Hanania T, Brunner D, Lukas RJ, Kozikowski AP.. (2012) Identification of novel α4β2-nicotinic acetylcholine receptor (nAChR) agonists based on an isoxazole ether scaffold that demonstrate antidepressant-like activity., 55 (2): [PMID:22148173] [10.1021/jm201301h] |